🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05957679
Recruiting Not applicable

MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

NCT05957679 · tracked via the Priya Life Science China tracker
Sponsor
Shengjing Hospital
Phase
Not applicable
Started
2023-01-01
Last updated
2026-02-12

Condition(s) studied

Spinal Cord Tumors

Investigational drug(s) / intervention(s)

Magnetic Resonance ElastographyAssessment and Recording

Magnetic Resonance Elastography: Undergo MRE and routine MRI

Assessment and Recording: Undergo grading and recording of tumor stiffness and adhesion during surgery

Study summary

In spinal cord tumors requiring surgical intervention, the resection difficulty is determined by two significant factors: tumor stiffness and adhesion to surrounding tissue.

The stiffness of the tumor dictates the complexity of removal, while strong adhesion presents additional challenges during the surgical procedure.

This clinical trial aims to assess the clinical utility of magnetic resonance elastography (MRE), in evaluating the stiffness and adhesion of spinal cord tumors and guiding surgical planning to selecting the most appropriate surgical approach for patients with spinal cord tumors.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * All patients undergoing spinal cord tumor resection surgery are eligible for inclusion in the study cohort. Exclusion Criteria: * Patients with metallic implants or foreign bodies in their bodies (pacemakers, artificial metallic heart valves, metal joints, metal implants, and those who cannot remove dentures, insulin pumps, or contraceptive rings) * Pregnant women in the first trimester (within three months) * Patients with severe claustrophobia or anxiety * Patients with severe fever * Patients who can not tolerate MRE * Patients with vascular malformations and aneurysms. * Patients who do not sign an informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shengjing Hospital Shenyang Liaoning Recruiting

More Shengjing Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05957679 on ClinicalTrials.gov ↗ ← All trials in China